Ismail Z, Fischer C, McCall WV. What characterizes late-life depression? Psychiatr Clin N Am. 2013;36:483–96.
Hall CA, Reynolds CF-III. Late-life depression in the primary care setting: challenges, collaborative care, and prevention. Maturitas. 2014;79:147–52.
Article PubMed PubMed Central Google Scholar
Haigh EAP, Boguchi OE, Sigmon ST, Blazer DG. Depression among older adults: a 20-year update on five common myths and misconceptions. Am J Geriatr Psychiatry. 2018;26:107–22.
Wilkowska-Chmielewska J, Szelenberger W, Wojnar M. Age-dependent symptomatology of depression in hospitalized patients and its implications for DSM-5. J Affect Disord. 2013;150:142–5.
Thorlund K, Druyts E, Wu P, Balijepalli C, Keohane D, Mille E. Comparative efficacy and safety of selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors in older adults: a network meta-analysis. J Am Geriatr Soc. 2015;63:1002–9.
Alexopoulos GS. Mechanisms and treatment of late-life depression. Transl Psychiatry. 2019;9:188.
Article PubMed PubMed Central Google Scholar
Gruver AL, Hudson LL, Sempowski GD. Immunoscenescence of ageing. J Pathol. 2007;211:144–56.
Article PubMed PubMed Central CAS Google Scholar
Franceschi C, Campisi J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J Gerontol Ser A Biol Sci Med Sci. 2014;69:54–9.
Forbes M, O’Neil A, Lane M, Agustini B, Myles N, Berk M. Major depressive disorder in older patients as an inflammatory disorder: implications for the pharmacological management of geriatric depression. Drugs Aging. 2021;38:451–67.
Dantzer R, Oconnor J, Lawson MA, Kelley KW. Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology. 2011;36:426–36.
Article PubMed CAS Google Scholar
Kiecolt-Glaser JK, Derry HM, Fagundes CP. Inflammation: depression fans the flames and feasts on the heat. Am J Psychiatry. 2015;172:1075–91.
Article PubMed PubMed Central Google Scholar
Miller AH. Beyond depression: the expanding role of inflammation in psychiatric disorders. World Psychiatry. 2020;19:108–9.
Article PubMed PubMed Central Google Scholar
Slavich GM, Irwin MR. From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull. 2014;140:774–815.
Article PubMed PubMed Central Google Scholar
Lucin KM, Wyss-Coray T. Immune activation in brain aging and neurodegeneration: too much or too little? Neuron. 2009;64:110–22.
Article PubMed PubMed Central CAS Google Scholar
Cianciulli A, Calvello R, Ruggiero M, Panaro MA. Inflammaging and brain: curcumin and its beneficial potential as regulator of microglia activation. Molecules. 2022;27:341.
Article PubMed PubMed Central CAS Google Scholar
Gorgoulis V, Adams PD, Alimonti A, Bennet DC, Bischof O, Bishop C, et al. Cellular senescence: defining a path forward. Cell. 2019;179:813–27.
Article PubMed CAS Google Scholar
Streit WJ, Sammons NW, Kuhns AJ, Sparks DI. Dystrophic microglia in the aging human brain. Glia. 2004;45:208–12.
Streit WJ, Braak H, Xue QS, Bechmann I. Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer’s disease. Acta Neuropathol. 2009;118:475–85.
Article PubMed PubMed Central Google Scholar
Cao D, Li XH, Luo XG, Yu HM, Wan LS, Wei L, et al. Phorbol myristate acetate induces cellular senescence in rat microglia in vitro. Int J Mol Med. 2020;46:415–26.
Article PubMed CAS Google Scholar
Wong WT. Microglial aging in the healthy CNS: phenotypes, drivers, and rejuvenation. Front Cell Neurosci. 2013;7:22.
Article PubMed PubMed Central CAS Google Scholar
Ransohoff RM. A polarizing question: do M1 and M2 microglia exist? Nat Neurosci. 2016;19:987–91.
Article PubMed CAS Google Scholar
Calvello R, Cianciulli A, Nicolardi G, De Nuccio F, Giannotti L, Salvatore R, et al. Vitamin D treatment attenuates neuroinflammation and dopaminergic neurodegeneration in an animal model of Parkinson’s disease, shifting M1 to M2 microglia responses. J Neuroimmune Pharmacol. 2017;12:327–39.
Guo S, Wang H, Yin Y. Microglia polarization from M1 to M2 in neurodegenerative diseases. Front Aging Neurosci. 2022;14:815347.
Article PubMed PubMed Central CAS Google Scholar
Cianciulli A, Porro C, Calvello R, Trotta T, Lofrumento DD, Panaro MA. Microglia mediated neuroinflammation: focus on PI3K modulation. Biomolecules. 2020;10:137.
Article PubMed PubMed Central CAS Google Scholar
Di Benedetto S, MuAaller L, Wenger E, Duzel S, Pawelec G. Contribution of neuroinflammation and immunity to brain aging and the mitigating effects of physical and cognitive interventions. Neurosci Biobehav Rev. 2017;75:114–28.
Tian L, Ma L, Kaarela T, Li Z. Neuroimmune crosstalk in the central nervous system and its significance for neurological diseases. J Neuroinflamm. 2012;9:155.
Abott NJ, Patabendige AAK, Dolman DEM, Yusof SR, Begley DJ. Structure and function of the blood–brain barrier. Neurobiol Dis. 2010;37:13–25.
Knox EG, Aburto MR, Clarke G, Cryan JF, O’Driscoll JM. The blood–brain barrier in aging and neurodegeneration. Mol Psychiatry. 2022;27:2659–73.
Article PubMed PubMed Central CAS Google Scholar
Yang AC, Stevens MY, Chen MB, Lee DP, Stahli D, Gate D, et al. Physiological blood–brain transport is impaired with age by a shift in transcytosis. Nature. 2020;583:425–30.
Article PubMed PubMed Central CAS Google Scholar
Elahy M, Jackaman C, Mamo JC, Lam V, Dhaliwal SS, Giles C, et al. Blood–brain barrier dysfunction developed during normal aging is associated with inflammation and loss of tight junctions but not with leukocyte recruitment. Immun Ageing. 2015;12:2.
Article PubMed PubMed Central Google Scholar
Erickson MA, Banks WA. Age-associated changes in the immune system and blood–brain barrier functions. Int J Mol Sci. 2019;20:1632.
Article PubMed PubMed Central CAS Google Scholar
Montagne A, Barnes SR, Sweeney MD, Halliday MR, Sagare AP, Zhao Z, et al. Blood–brain barrier breakdown in the aging human hippocampus. Neuron. 2015;85:296–302.
留言 (0)